Jass J R, Stewart S M, Stewart J, Lane M R
Department of Pathology, School of Medicine, University of Auckland, New Zealand.
Mutat Res. 1994 Oct 1;310(1):125-33. doi: 10.1016/0027-5107(94)90016-7.
Mutations in a human homologue of the yeast DNA mismatch repair gene MSH2 (equivalent to bacterial MutS) cause the condition hereditary non-polyposis colorectal cancer (HNPCC). Cancers in HNPCC originate within benign neoplastic polyps termed adenomas. Adenomas are clonal and each may serve as a marker of a single initiating mutation. The progression of adenomas is marked by increasing size, dysplasia and villosity. These characteristics can be taken as the morphological counterparts of the stepwise accumulation of mutations implicating oncogenes and tumour suppressor genes. The aim of this study was to link the morphogenesis of hereditary colorectal cancer with recent insights into the role of DNA mismatch repair genes. The frequency and anatomical distribution of adenomas in at-risk members of HNPCC families was the same as in an autopsy population. This suggests that the HNPCC gene does not initiate the process of neoplastic transformation. On the other hand, adenomas in at-risk members of HNPCC families were more likely to show villosity (p < 0.001), high grade dysplasia (p = 0.002) and probably increased size (p = 0.15). These findings are consistent with the observation that the HNPCC gene causes DNA replication errors to develop and accumulate within neoplastic but not normal tissues. The effect of the HNPCC gene is to accelerate the progression of adenoma to carcinoma, but not to initiate adenoma development.
酵母DNA错配修复基因MSH2(等同于细菌MutS)的人类同源基因发生突变会导致遗传性非息肉病性结直肠癌(HNPCC)。HNPCC中的癌症起源于称为腺瘤的良性肿瘤性息肉。腺瘤是克隆性的,每个腺瘤都可作为单个起始突变的标志物。腺瘤的进展以大小增加、发育异常和绒毛状化为特征。这些特征可被视为涉及癌基因和肿瘤抑制基因的突变逐步积累的形态学对应物。本研究的目的是将遗传性结直肠癌的形态发生与对DNA错配修复基因作用的最新认识联系起来。HNPCC家族高危成员中腺瘤的频率和解剖分布与尸检人群相同。这表明HNPCC基因不会启动肿瘤转化过程。另一方面,HNPCC家族高危成员中的腺瘤更有可能表现出绒毛状化(p < 0.001)、高级别发育异常(p = 0.002),并且可能大小增加(p = 0.15)。这些发现与以下观察结果一致,即HNPCC基因导致DNA复制错误在肿瘤组织而非正常组织中发生和积累。HNPCC基因的作用是加速腺瘤向癌的进展,但不是启动腺瘤的发生。